Home › Rhabdoid Tumor › California
Rhabdoid Tumor clinical trials in California
4 studies for Rhabdoid Tumor are looking for participants at sites in California.
Cities in California
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Lucile Packard Children's Hospital Stanford, Palo Alto
RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Sep 11, 2026 · NCT07087002Study of Novel Therapies for Young People With Recurrent/Progressive Atypical Teratoid Rhabdoid Tumor (ATRT)
- University of California, San Francisco, San Francisco
- University of California, San Francisco, San Francisco
RecruitingPhase 2
Ages 1 to 39 · All sexes · Updated Jun 23, 2026 · NCT07447076Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Children's Hospital of Los Angeles (Data Collection Only), Los Angeles
- Stanford Medicine Children's Health (Data Collection Only), Palo Alto
RecruitingPhase 2
12 Months · All sexes · Updated May 6, 2026 · NCT05985161From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.